The latest Investing Matters Podcast episode with Inclusive Asset Management's Alexandra McGuigan has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,610.50
Bid: 1,607.50
Ask: 1,608.00
Change: -33.00 (-2.01%)
Spread: 0.50 (0.031%)
Open: 1,626.50
High: 1,626.50
Low: 1,594.50
Prev. Close: 1,643.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET PULSE-AMD, Cbeyond, Halliburton, Plug Power, Prosensa, Sarepta

Mon, 21st Apr 2014 14:00

(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s)

April 21 (Reuters) - U.S. stocks opened flat on Monday as investors found few reasonsto keep buying following a strong rally last week and ahead of aheavy week of corporate earnings. The Dow Jones industrialaverage was up 0.25 percent at 16,448.9, the S&P 500 was up 0.22 percent at 1,868.98 and the Nasdaq Composite was up 0.26 percent at 4,106.1.

** HALLIBURTON CO, $63.289, +3.92 pct

The world's No. 2 oilfield services company, reportedbetter-than-expected quarterly results, helped by robustdrilling activity in Russia, Saudi Arabia and Angola.

** HASBRO INC, $55.255, +1.18 pct

The toymaker reported a quarterly profit, compared with ayear-ago loss, helped by strong demand for its toys for girls.Sales of girls' toys such as My Little Pony and Nerf Rebelleincreased 21 percent to $138.7 million in the first quarterended March 30.

** SAREPTA THERAPEUTICS INC, $36.8001, +50.82 pct

** PROSENSA HOLDING NV, $5.55, +9.47 pct

Sarepta said it would start new trials to revive the chanceof approval for its experimental muscle disorder drug after theU.S. Food and Drug Administration advised the company to submitnew safety and efficacy data.

Prosensa makes drisapersen, a competing drug that failed alate-stage trial in September 2012.

** TEVA PHARMACEUTICAL INDUSTRIES LTD, $51.01,+0.31 pct

** MYLAN INC, $47.94, +2.17 pct

** MOMENTA PHARMACEUTICALS INC, $11.9984, +8.09 pct

The U.S. Supreme Court on Friday denied a request by Teva tostay a lower-court ruling in a patent case that favored thedevelopers of generic versions of the Israel-based company'stop-selling multiple sclerosis drug Copaxone.

The decision could help pave the way for generic competitorsof Teva's Copaxone drug to go on the market as soon as nextmonth.

The lower-court ruling in July 2013 was in favor of twoteams developing cheaper generic forms of Copaxone: onecomprising Novartis AG's Sandoz Inc and MomentaPharmaceuticals, and the other comprising Mylan Inc andNatco Pharma Ltd.

** CBEYOND INC, $9.79, +38.28 pct

Privately held enterprise Internet-based communicationsservices provider Birch Communications Inc said it agreed to buythe data center and networking services provider Cbeyond Inc forabout $323 million in cash to expand its optical fiber and datacenter network.

Cbeyond shareholders will get between $9.97 and $10 pershare. At $9.97 per share, the offer represents a premium of40.8 percent over the closing price of Cbeyond's stock onThursday.

** PLUG POWER, $8.03, +9.70 pct

The US fuel cell maker said on Monday Chief Executive AndyMarsh will provide update on the company's plans for its GenKeyhydrogen fuel cells, and ReliOn acquisition At 10 am ET.

** ADVANCED MICRO DEVICES INC, $4.14, +12.20 pct

The chipmaker reported better-than-expected quarterlyresults on Thursday and its second-quarter revenue forecast wasabove analysts' estimates.

At least two brokerages raised their price targets on thestock on Monday.

** CALPINE CORP, $22.28, +4.26 pct

U.S. power and energy infrastructure owner LS Power EquityAdvisors LLC said it has agreed to buy about 3,500 MW ofgeneration resources in the southeastern United States fromCalpine for $1.57 billion. The portfolio consists of sixcombined-cycle generation facilities which use natural gas asthe primary fuel source, LS Power Equity said.

Calpine mainly owns and operates natural gas-fired andgeothermal power plants in North America.

** PERFECT WORLD CO LTD, $19.335, -1.20 pct

** SHANDA GAMES LTD, $6.71, +1.36 pct

China-based online game developer Perfect World said itjoined the consortium offering to buy rival Shanda Games.Perfect World said it would buy 30.3 million class A ShandaGames shares for $100 million from Shanda InteractiveEntertainment Ltd, a shareholder in Shanda Games.

** NU SKIN ENTERPRISES INC, $87.52, +1.27 pct

The direct-selling skincare and nutritional product companyon Saturday said its Nu Skin China unit plans to immediatelyresume corporate-hosted business meetings and will beginaccepting applications for new sales people on May 1.

"China is an important marketplace for Nu Skin and we arecommitted to operating in full compliance with China's directselling regulations to promote long-term success," the companysaid in a statement.

** TREEHOUSE FOODS INC, $72.38, +0.32 pct

The food manufacturer said it will acquire Canada-basedProtenergy Natural Foods from Whitecastle Investments Ltd,Whitecap Venture Partners and others for about C$170 million.

Protenergy Natural Foods makes private-label broth, soupsand gravies.

** GENERAL MOTORS CO, $33.95, -0.09 pct

The U.S. car giant plans to invest $12 billion in China from2014 to 2017 and build more plants next year as it competes withaggressive rivals in the world's largest auto market.

** NEWMONT MINING CORP, $25.01, +6.24 pct

The talks between Barrick Gold Corp and NewmontMining over a combination that would create a gold miningbehemoth have hit a snag, but two sources close to the situationsay the companies remain keen on a deal and discussions arelikely to resume.

** PFIZER INC, $30.71, +1.52 pct

The U.S. pharmaceutical giant has approached British rivalAstraZeneca Plc to propose a 60 billion pound ($101billion) takeover, Britain's Sunday Times reported.

** APPLE INC, $527.78, +0.54 pct

** GOOGLE INC, $539.44, -0.72 pct

Apple and Google are wooing game developers to ensure thattop game titles arrive first on devices powered by theirrespective operating system, the Wall Street Journal reported,citing people familiar with the matter.

** COMCAST CORP, $49.61, +1.04 pct

** CHARTER COMMUNICATIONS INC, $121.75, +3.33 pct

Comcast is in talks with Charter Communications over sellingor spinning off roughly 3 million subscribers worthapproximately $18 billion to $20 billion as part of thedivestitures related to its $45.3 billion takeover of TimeWarner Cable, according to a source familiar with thematter.

** VIMPELCOM LTD, $9.325, +3.61 pct

Russia's Vimpelcom has resolved a long-running dispute withthe Algerian government by selling it a majority stake in thecountry's biggest telecoms operator for $2.6 billion, while itwill keep control and slash debt.

** WALT DISNEY CO, $79.49, -0.63 pct

Walt Disney Co's cable networks are expected to record highsingle-digit growth in operating income and domestic affiliaterevenue from fiscal 2014 through 2016, Chief Financial OfficerJay Rasulo told investors on Thursday.

** SPRINT CORP, $8.57, +0.59 pct

** T-MOBILE US INC, $30.44, +0.13 pct

A possible merger between Sprint and T-Mobile could promptU.S. regulators to rewrite rules they are now weighing for a2015 auction of airwaves, according to sources familiar with theproposed regulations.

** LULULEMON ATHLETICA INC, $49.854, -3.59 pct

A U.S. judge has issued final dismissals of lawsuitsaccusing Lululemon and various company officials of defraudingshareholders by concealing defects in yoga pants.

** ATHENAHEALTH, $138.736, -4.70 pct

The healthcare IT services company on Thursday reportedfirst-quarter adjusted earnings and revenue that fell below WallStreet estimates.

Three brokerages, including Oppenheimer, Deutsche Bank andB. Riley cut their price targets on the company' stock, citingweakness in its Epocrates business - a mobile medicalapplication.

** SELECT COMFORT CORP, $18.98, +6.93 pct

The specialty mattress maker on Thursday reportedfirst-quarter sales that beat analysts' estimates, helped by a 2percent rise in comparable sales.

** WEIBO CORP, $22.65, +11.91 pct

The Chinese Twitter-like messaging service company'sU.S.-listed shares were up premarket on Monday after they soared19 percent on their debut on Thursday.

** UNITEDHEALTH GROUP INC, $76.3, +0.69 pct

The largest U.S. health insurer, said it spent more than$100 million to cover a pricey new hepatitis C drug from GileadSciences Inc in its first three months on the market,an amount that was "multiple" times what it had expected.

** ABBOTT LABORATORIES, $38.81, -0.31 pct

An Abbott Laboratories spinoff urged a federal appealscourt to revisit a ruling in a case against GlaxoSmithKline Plc, but without disturbing landmark constitutionalprotections for gays and lesbians.

** KRAFT FOODS GROUP INC, $56.83, -0.14 pct

Kraft Foods is recalling about 96,000 pounds of Oscar MayerClassic Wieners because the packages may instead contain ClassicCheese Dogs made with milk, a known allergen.

** PLATINUM UNDERWRITERS HOLDINGS LTD, $62.35, +0.31pct

Brokerage Keefe Bruyette & Woods raised the reinsuranceprovider's target price to $69 from $67, after the company'searnings for the quarter ended March 31 beat analysts' estimateswith strong underwriting, investing, and capital managementperformance. The company reported earnings per share of $2.27,higher than analysts' average estimate of $1.28, according toThomson Reuters I/B/E/S. [ID: nPn5HRfMd]

** AMERICAN TOWER CORP, $82.44, -0.25 pct

Indian conglomerate Reliance Industries Ltd' telecommunications unit, which holds nationwide 4G permits, hasagreed to lease mobile phone masts from infrastructure providerAmerican Tower Corp's local arm, the companies said in astatement on Monday.

** CHINDEX INTERNATIONAL INC, $23.69, +3.27 pct

Chinese drugmaker Shanghai Fosun Pharmaceutical Group Co Ltd has raised its offer for U.S.-listed ChindexInternational Inc by 15 percent to $223.6 million aftera bidding war for the China-focused hospital chain.

** PEOPLE'S UNITED FINANCIAL INC, $14.65, +0.76 pct

Brokerage Keefe Bruyette & Woods cut the lender's targetprice to $14.50 from $15, citing low profitability until thecompany improves return on assets and efficiency ratio.

** PRIVATEBANCORP INC, $29.93, +1.15 pct

KBW raised its price target on the stock to $34 from $33after the bank reported better-than-expected first quarterresults on Thursday, helped by commercial loan growth.

** LINEAR TECHNOLOGY CORP, $46.33, -0.09 pct

The analog chipmaker said on Thursday it expects revenue togrow 2-6 percent from $348 million in the third quarter, that is$355-$369 million. Analysts on average were expecting revenue of$365 million, according to Thomson Reuters I/B/E/S.

** RADIOSHACK CORP, $1.47, +4.26 pct

The struggling U.S. electronics chain is mired in talks withits lenders over its plans to close about 1,100 stores,complicating its turnaround efforts, the Wall Street Journalreported, citing sources close to the talks.

RadioShack, which operates about 4,300 stores in the UnitedStates, said in March that the plan needed permission from itslenders, adding that its credit agreements allowed it to closeonly about 200 stores without the approval of lead lenders, theJournal said late on Wednesday. (http://r.reuters.com/vyg68v)

The company reported a wider quarterly loss and a huge dropin sales during the holiday season.

** BIOGEN IDEC INC, $294.058, +1.21 pct

Biogen is pricing its newly approved long-acting hemophiliadrug, Alprolix, to cost U.S. patients, and insurers, about thesame per year as older, less convenient therapies whose pricecan reach about $300,000 annually.

The move could pressure rivals such as Pfizer Inc tolower prices for existing hemophilia treatments, which providepatients with life-saving infusions of a blood clotting agent,according to doctors and industry analysts.

** HILLSHIRE BRANDS CO, $36.14, +0.08 pct

The maker of Jimmy Dean sausages and Ball Park hot dogs saidit has signed a definitive agreement to acquire Van's NaturalFoods from private equity firm Catterton Partners for about $165million to expand its presence in the frozen foods category.

Van's Natural Foods makes frozen waffles and breakfastsandwiches, as well as gluten-free cereals and crackers. (Compiled by Rohit T.K. in Bangalore; Editing by Joyjeet Das)

More News
Today 09:17

GSK meningococcal vaccine accepted by US FDA for review

(Sharecast News) - GSK announced on Tuesday that its five-in-one meningococcal ABCWY (MenABCWY) vaccine candidate had been accepted for regulatory review by the US Food and Drug Administration (FDA).

Read more
Today 08:59

GSK's latest meningitis vaccine accepted for review by US regulator

(Alliance News) - GSK PLC on Tuesday said it has made progress in the development of its newest candidate, which combines the strengths of two other vaccines in its portfolio into one bacteria-fighting inoculation.

Read more
11 Apr 2024 18:51

AstraZeneca CEO could earn 19 million pounds as pay measure clears opposition

Policy approved with two-third of votes in favour

*

Read more
9 Apr 2024 11:45

Pfizer RSV shot meets goals in trial of high-risk adults under age 60

April 9 (Reuters) - Pfizer said on Tuesday its respiratory syncytial virus (RSV) vaccine Abrysvo was well tolerated and generated an immune response in higher risk adults under the age of 60 similar to that in older adults, for whom the shot is already approved.

Read more
8 Apr 2024 09:13

LONDON BROKER RATINGS: Wizz Air raised; HSBC cuts Rentokil to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
4 Apr 2024 13:08

UK dividends calendar - next 7 days

Friday 5 April 
BBGI Global Infrastructure SAdividend payment date
Molten Ventures PLCdividend payment date
Pennon Group PLCdividend payment date
Real Estate Credit Investments Ltddividend payment date
Regional REIT Ltddividend payment date
Rights & Issues Investment Trust PLCdividend payment date
Sylvania Platinum Ltddividend payment date
Titon Holdings PLCdividend payment date
Triple Point Energy Transition PLCdividend payment date
Monday 8 April 
Alumasc Group PLCdividend payment date
LondonMetric Property PLCdividend payment date
Redrow PLCdividend payment date
Tuesday 9 April 
CT Global Managed Portfolio Trust PLCdividend payment date
Downing Strategic Micro-Cap Investment Trust PLCdividend payment date
Dunelm Group PLCspecial dividend payment date
Hays PLCdividend payment date
Renishaw PLCdividend payment date
Safestore Holdings PLCdividend payment date
Wednesday 10 April 
Assura PLCdividend payment date
Primorus Investments PLCspecial dividend payment date
Wilmington PLCdividend payment date
Thursday 11 April 
Amedeo Air Four Plus Ltdex-dividend payment date
Athelney Trust PLCdividend payment date
Aviva PLCex-dividend payment date
Balanced Commercial Property Trust Ltdex-dividend payment date
Barratt Developments PLCex-dividend payment date
Begbies Traynor Group PLCex-dividend payment date
Bioventix PLCex-dividend payment date
Blackfinch Spring VCT PLCex-dividend payment date
BlackRock Latin American Investment Trust PLCex-dividend payment date
Caledonia Mining Corpex-dividend payment date
Capital & Regional PLCex-dividend payment date
Chesnara PLCex-dividend payment date
Colefax Group PLCdividend payment date
CT Private Equity Trust PLCex-dividend payment date
Downing Strategic Micro-Cap Investements Trust PLCex-dividend payment date
Driver Group PLCdividend payment date
F&C Investment Trust PLCex-dividend payment date
Foxtons Group PLCex-dividend payment date
Grafton Group PLCex-dividend payment date
GSK PLCdividend payment date
Harbour Energy PLCex-dividend payment date
Hargreaves Services PLCdividend payment date
Howden Joinery Group PLCex-dividend payment date
Hunting PLCex-dividend payment date
i3 Energy PLCex-dividend payment date
International Personal Finance PLCex-dividend payment date
International Public Partnerships Ltdex-dividend payment date
ITV PLCex-dividend payment date
Johnson Service Group PLCex-dividend payment date
JPMorgan Asia Growth & Income PLCex-dividend payment date
JPMorgan Japan Small Cap Growth & Income PLCex-dividend payment date
Just Group PLCex-dividend payment date
Kenmare Resources PLCex-dividend payment date
Kerry Group PLCex-dividend payment date
Kings Arms Yard VCT PLCex-dividend payment date
Law Debenture Corp PLCdividend payment date
Lloyds Banking Group PLCex-dividend payment date
Lowland Investment Cos PLCex-dividend payment date
Luceco PLCex-dividend payment date
Man Group PLCex-dividend payment date
Manchester & London Investement Trust PLCex-dividend payment date
Marble Point Loan Financing Ltdex-dividend payment date
Mercantile Investment Trust PLCex-dividend payment date
Mobius Investment Trust PLCex-dividend payment date
MTI Wireless Edge Ltddividend payment date
North American Income Trust PLCex-dividend payment date
Northamber PLCex-dividend payment date
Octopus Apollo VCT PLCex-dividend payment date
Phoenix Group Holdings PLCex-dividend payment date
Reckitt Benckiser Group PLCex-dividend payment date
Ricardo PLCdividend payment date
Savills PLCex-dividend payment date
Schroder Asian Total Return Investment Cos PLCex-dividend payment date
Schroder European Real Estate Investment Trust PLCex-dividend payment date
Scottish American Investment Cos PLCdividend payment date
Smurfit Kappa Group PLCex-dividend payment date
Softcat PLCex-dividend payment date
Somero Enterprises Incex-dividend payment date
Supermarket Income REIT PLCex-dividend payment date
Synectics PLCex-dividend payment date
TP ICAP Group PLCex-dividend payment date
Trifast PLCdividend payment date
TT Electronics PLCex-dividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 14-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
4 Apr 2024 00:03

Sanofi to settle 4,000 Zantac cancer lawsuits in US state courts

NEW YORK, April 3 (Reuters) - Sanofi has reached an agreement in principle to settle 4,000 U.S. lawsuits linking the discontinued heartburn drug Zantac to cancer, the company said on Wednesday.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 21:37

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, April 3 (Reuters) - Texas officials reported on Monday that a farm worker tested positive for H5N1, or bird flu, that has spread to dairy cows in Texas, Kansas, New Mexico, Michigan and Idaho - the first time the virus has infected cattle.

Read more
19 Mar 2024 09:21

LONDON BROKER RATINGS: Investec cuts ConvaTec; RBC raises Vistry

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
18 Mar 2024 12:00

GSK unveils promising results from endometrial cancer trial

(Sharecast News) - GSK unveiled promising outcomes from a phase three trial of 'Jemperli', or dostarlimab, in treating primary advanced or recurrent endometrial cancer on Monday.

Read more
18 Mar 2024 08:47

TOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in Haleon

(Alliance News) - Haleon PLC on Monday said Pfizer Inc plans to sell around GBP2 billion in Haleon shares, some of which will be bought back by Haleon.

Read more
18 Mar 2024 08:47

GSK says Jemperli combination gets good results for endometrial cancer

(Alliance News) - GSK PLC on Monday said a test of its Jemperli drug in combination with chemotherapy has shown it reduced the risk of death in patients with endometrial cancer by nearly a third.

Read more
7 Mar 2024 09:38

GSK observes positive data in Blenrep trial for blood cancer treatment

(Alliance News) - GSK PLC on Thursday announced positive results for Blenrep for the treatment of multiple myeloma.

Read more
7 Mar 2024 07:21

GSK reports more encouraging trial results for Blenrep

(Sharecast News) - GSK unveiled encouraging results from its 'DREAMM-8' phase three trial on Thursday, comparing the efficacy of 'Blenrep', or belantamab mafodotin, in combination with pomalidomide plus dexamethasone, or PomDex, against the standard treatment of bortezomib plus PomDex in relapsed or refractory multiple myeloma patients.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.